Circular RNA circREPS2 Acts as a Sponge of miR-558 to Suppress Gastric Cancer Progression by Regulating RUNX3/β-catenin Signaling.

EMT RUNX3 circREPS2 gastric cancer miR-558

Journal

Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621

Informations de publication

Date de publication:
04 Sep 2020
Historique:
received: 19 01 2020
revised: 17 03 2020
accepted: 24 06 2020
pubmed: 30 7 2020
medline: 30 7 2020
entrez: 30 7 2020
Statut: ppublish

Résumé

Circular RNAs (circRNAs) play an essential regulatory role in multiple cancers. However, the role of a large number of circRNAs in gastric cancer (GC) is still unknown. Here, hsa_circ_0139996 (circREPS2), a novel circRNA that was significantly downregulated in GC, was selected for further investigation. circREPS2 was validated and analyzed by DNA sequencing and quantitative real-time PCR. The roles of circREPS2 in GC cells were verified by gain- and loss-of-function experiments. Bioinformatics analysis, luciferase reporter, RNA pull-down, and RNA immunoprecipitation assays were performed to evaluate the functional mechanism of circREPS2 on microRNA-558 (miR-558)/RUNX3/β-catenin axis in GC cells. In the present study, we found that circREPS2 was downregulated in GC tissues and cell lines. Low expression of circREPS2 was associated with a higher tumor-node-metastasis (TNM) stage, poor tumor differentiation, and larger tumor size in GC patients. Functionally, circREPS2 significantly inhibited GC cell proliferation, migration, invasion, and epithelial-mesenchymal transformation (EMT) in vitro and tumorigenesis in vivo. Furthermore, our data demonstrated that circREPS2 acted as a miR-558 sponge and upregulated RUNX3 expression to inactivate β-catenin signaling in GC cells. In conclusion, circREPS2 suppresses the progression of GC via miR-558/RUNX3/β-catenin signaling and is a novel promising biomarker and target for GC treatment.

Identifiants

pubmed: 32721878
pii: S2162-2531(20)30187-6
doi: 10.1016/j.omtn.2020.06.026
pmc: PMC7390859
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

577-591

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Références

RNA Biol. 2016;13(1):34-42
pubmed: 26669964
J Gastrointest Surg. 2016 Oct;20(10):1692-8
pubmed: 27412320
Mol Cancer. 2019 Oct 29;18(1):149
pubmed: 31660951
Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52
pubmed: 25378301
Oncogene. 2012 Sep 27;31(39):4302-16
pubmed: 22231444
J Exp Clin Cancer Res. 2018 Dec 27;37(1):325
pubmed: 30591054
Genome Med. 2019 Mar 20;11(1):15
pubmed: 30894216
Genome Biol. 2019 Sep 2;20(1):185
pubmed: 31477170
Lancet. 2015 Mar 14;385(9972):977-1010
pubmed: 25467588
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Lancet. 2016 Nov 26;388(10060):2654-2664
pubmed: 27156933
Elife. 2015 Aug 12;4:
pubmed: 26267216
Nat Rev Mol Cell Biol. 2016 Apr;17(4):205-11
pubmed: 26908011
RNA. 2014 Nov;20(11):1666-70
pubmed: 25234927
Biochim Biophys Acta. 2009 Dec;1796(2):315-31
pubmed: 19682550
PLoS One. 2018 Oct 18;13(10):e0206239
pubmed: 30335862
Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a002915
pubmed: 20182623
Nucleic Acids Res. 2017 Jan 4;45(D1):D90-D96
pubmed: 27742822
Nat Commun. 2019 Sep 20;10(1):4317
pubmed: 31541092
Nat Rev Cancer. 2013 Feb;13(2):97-110
pubmed: 23344542
EBioMedicine. 2019 Oct;48:316-331
pubmed: 31648990
Cell Prolif. 2019 Mar;52(2):e12548
pubmed: 30507050
Cancer Lett. 2015 Sep 1;365(2):141-8
pubmed: 26052092
RNA Biol. 2017 May 4;14(5):514-521
pubmed: 26649774
Nucleic Acids Res. 2018 Jan 4;46(D1):D360-D370
pubmed: 29194489
BMC Bioinformatics. 2013;14 Suppl 2:S4
pubmed: 23369107
Stem Cells. 2012 Oct;30(10):2088-99
pubmed: 22899304
Cell Res. 2012 Jan;22(1):237-47
pubmed: 21826110
Gastroenterology. 2018 Sep;155(3):799-814.e13
pubmed: 29775598
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
Cancer Cell. 2008 Sep 9;14(3):226-37
pubmed: 18772112
Nat Rev Genet. 2019 Nov;20(11):675-691
pubmed: 31395983
Aging (Albany NY). 2019 Nov 13;11(21):9689-9708
pubmed: 31719211
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Mol Ther Nucleic Acids. 2020 Jun 5;20:308-322
pubmed: 32193155

Auteurs

Xiong Guo (X)

Department of Gastrointestinal Surgery, Laboratory Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China.

Xinglong Dai (X)

Department of Gastrointestinal Surgery, Laboratory Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China.

Jianjun Liu (J)

Department of Gastrointestinal Surgery, Laboratory Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China.

Anqi Cheng (A)

Department of Gastrointestinal Surgery, Laboratory Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China.

Chuan Qin (C)

Department of Gastrointestinal Surgery, Laboratory Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China; Department of Gastrointestinal Surgery, Three Gorges Hospital, Chongqing University, Chongqing 404000, P.R. China.

Ziwei Wang (Z)

Department of Gastrointestinal Surgery, Laboratory Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, P.R. China. Electronic address: ziweiwang1@sina.com.

Classifications MeSH